Byington R - Search Results

1

Increasing utilization of dermatologists by managed care: an analysis of the National Ambulatory Medical Care Survey, 1990-1994.

Feldman SR, Fleischer AB Jr, Williford PM, White R, Byington R. Feldman SR, et al. Among authors: byington r. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):784-8. doi: 10.1016/s0190-9622(97)70118-x. J Am Acad Dermatol. 1997. PMID: 9366831

2

Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the National Ambulatory Medical Care Survey.

Fleischer AB Jr, Feldman SR, White RE, Leshin B, Byington R. Fleischer AB Jr, et al. Among authors: byington r. J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):719-24. doi: 10.1016/s0190-9622(97)70107-5. J Am Acad Dermatol. 1997. PMID: 9366816 Clinical Trial.

3

Pravastatin, lipids, and major coronary events.

Furberg CD, Byington RP, Crouse JR, Espeland MA. Furberg CD, et al. Among authors: byington rp. Am J Cardiol. 1994 Jun 1;73(15):1133-4. doi: 10.1016/0002-9149(94)90297-6. Am J Cardiol. 1994. PMID: 8198043 Clinical Trial. No abstract available.

4

Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).

Byington RP, Miller ME, Herrington D, Riley W, Pitt B, Furberg CD, Hunninghake DB, Mancini GB. Byington RP, et al. Am J Cardiol. 1997 Oct 15;80(8):1087-90. doi: 10.1016/s0002-9149(97)00611-5. Am J Cardiol. 1997. PMID: 9352986

5

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).

Crouse JR 3rd, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD. Crouse JR 3rd, et al. Among authors: byington rp. Am J Cardiol. 1995 Mar 1;75(7):455-9. doi: 10.1016/s0002-9149(99)80580-3. Am J Cardiol. 1995. PMID: 7863988 Clinical Trial.

6

Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.

Byington RP, Worthy J, Craven T, Furberg CD. Byington RP, et al. Am J Cardiol. 1990 Jun 1;65(20):1287-91. doi: 10.1016/0002-9149(90)91314-v. Am J Cardiol. 1990. PMID: 2188492 Clinical Trial.

7

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data.

Crouse JR 3rd, Byington RP, Furberg CD. Crouse JR 3rd, et al. Among authors: byington rp. Atherosclerosis. 1998 May;138(1):11-24. doi: 10.1016/s0021-9150(98)00014-8. Atherosclerosis. 1998. PMID: 9678767 Review.

8

Long term propranolol treatment and changes in body weight after myocardial infarction.

Rössner S, Taylor CL, Byington RP, Furberg CD. Rössner S, et al. Among authors: byington rp. BMJ. 1990 Apr 7;300(6729):902-3. doi: 10.1136/bmj.300.6729.902. BMJ. 1990. PMID: 2186832 Free PMC article. Clinical Trial.

9

Reductase inhibitor monotherapy and stroke prevention.

Crouse JR 3rd, Byington RP, Hoen HM, Furberg CD. Crouse JR 3rd, et al. Among authors: byington rp. Arch Intern Med. 1997 Jun 23;157(12):1305-10. Arch Intern Med. 1997. PMID: 9201004

10

[Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program].

Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, Furberg CD, Mancini GB. Byington RP, et al. Fortschr Med. 1996 Mar 20;114(8):91-8. Fortschr Med. 1996. PMID: 8647574 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters